Department of Endodontics, Faculty of Dentistry, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
Faculty of Dentistry, University of Toronto, Toronto, Ontario, Canada.
Int Endod J. 2022 Apr;55(4):374-390. doi: 10.1111/iej.13675. Epub 2021 Dec 29.
In order to obtain a 3-dimentional scaffold with predictable clinical results for pulp regeneration, this study aims to fabricate and characterize a porous decellularized human amniotic membrane (HAM) extracellular matrix (ECM) scaffold, and evaluate its potential to promote pulp regeneration in vitro and in vivo.
The HAM was decellularized, and its histology and DNA content were analysed to confirm decellularization. The scaffolds were synthesized with 15, 22.5 and 30 mg/ml concentrations. The porosity, pore size, phosphate-buffered saline (PBS) absorption and degradation rate of the scaffolds were assessed. In vitro experiments were performed on human dental pulp stem cells (hDPSCs) to assess their viability, proliferation, adhesion and migration on the scaffolds. The optimal group was selected for in vivo immunogenicity assessment and was also used as the cell-free or cell-loaded scaffold in root segment models to evaluate pulp regeneration. All nonparametric data were analysed with the Kruskal-Wallis test followed by Dunn's post hoc test, whilst quantitative data were analysed with one-way anova.
Decellularization of HAM was confirmed (p < .05). The porosity of all scaffolds was more than 95%, and the pore size decreased with an increase in ECM concentration (p < .01). PBS absorption was not significantly different amongst the groups, whilst 30 mg/ml ECM scaffold had the highest degradation rate (p < .01). The hDPSCs adhered to the scaffold, whilst their proliferation rate increased over time in all groups (p < .001). Cell migration was higher in 30 mg/ml ECM scaffold (p < .05). In vivo investigation with 30 mg/ml ECM scaffold revealed mild to moderate inflammatory response. In root segments, both cell-free and cell-loaded 30 mg/ml scaffolds were replaced with newly formed, pulp-like tissue with no significant difference between groups. Immunohistochemical assessments revealed high revascularization and collagen content with no significant difference amongst the groups.
The 30 mg/ml HAM ECM scaffold had optimal physical properties and better supported hDPSC migration. The HAM ECM scaffold did not interfere with formation of pulp-like tissue and revascularization within the root canal when employed as both cell-free and cell-loaded scaffold. These results highlight the potential of HAM ECM membrane for further investigations in regenerative endodontics.
为了获得具有可预测临床效果的牙髓再生三维支架,本研究旨在制备和表征多孔去细胞人羊膜(HAM)细胞外基质(ECM)支架,并评估其在体外和体内促进牙髓再生的潜力。
对 HAM 进行去细胞处理,分析其组织学和 DNA 含量以确认去细胞化。支架用 15、22.5 和 30mg/ml 浓度合成。评估支架的孔隙率、孔径、磷酸盐缓冲盐水(PBS)吸收和降解率。在体外实验中,用人牙髓干细胞(hDPSC)评估其在支架上的活力、增殖、黏附和迁移。选择最佳组进行体内免疫原性评估,并将其作为无细胞或细胞负载支架用于根管段模型,以评估牙髓再生。所有非参数数据均采用 Kruskal-Wallis 检验,然后采用 Dunn 事后检验,而定量数据则采用单因素方差分析。
HAM 的去细胞化得到了证实(p<0.05)。所有支架的孔隙率均超过 95%,随着 ECM 浓度的增加,孔径减小(p<0.01)。各组间 PBS 吸收无显著差异,而 30mg/ml ECM 支架的降解率最高(p<0.01)。hDPSC 黏附在支架上,而在所有组中,其增殖率随时间增加(p<0.001)。30mg/ml ECM 支架的细胞迁移率更高(p<0.05)。体内研究显示,30mg/ml ECM 支架的炎症反应为轻度至中度。在根管段中,无细胞和细胞负载的 30mg/ml 支架均被新形成的牙髓样组织所取代,各组间无显著差异。免疫组织化学评估显示,血管生成和胶原含量较高,各组间无显著差异。
30mg/ml HAM ECM 支架具有最佳的物理性能,更好地支持 hDPSC 迁移。当用作无细胞和细胞负载支架时,HAM ECM 支架不会干扰根管内牙髓样组织和血管形成。这些结果突出了 HAM ECM 膜在再生牙髓学中进一步研究的潜力。